中文 | English
Return
Total: 103 , 1/11
Show Home Prev Next End page: GO
Author:(Gui-xiang XU)

2.Establishment of a 15 loci multiplex amplification system and the genetic poly- morphism in Xinjiang Uygur population.

Juan GUI ; Hai-Bo LIU ; Qin-Xiang LIAO ; Xu XU ; Di LU ; Li YUAN

Journal of Forensic Medicine 2015;31(1):23-27

3.Selective COX-2 inhibitor versus nonselective COX-1 and COX-2 inhibitor in the prevention of heterotopic ossification after total hip arthroplasty: a meta-analysis of randomised trials.

Bu-Guo XU ; De-Ting XUE ; Xiang-Hua WANG ; Shi-Gui YAN

China Journal of Orthopaedics and Traumatology 2014;27(7):609-614

5.Analysis of the reconstruction of binocular visual function in 76 cases of pediatric ocular trauma

Ling, WANG ; Gui-Xiang, LIU ; Zhi-Juan, XU ; Ai-Hua, ZHANG

International Eye Science 2011;11(6):954-957

6.Recombinant human brain natriuretic peptide on the cardiac hemodynamics and renal function in dogs with heart failure.

Xiang-wei XU ; Gui-yun ZENG ; Yi YANG ; Hou-xiao LIU

Acta Pharmaceutica Sinica 2002;37(10):758-762

7.Withdrawal of steroid in kidney transplantation recipients

Er-Dun BAO ; Xiang-Hui WANG ; Da XU ; Gui-Min LING ; Xiao-Da TANG

Journal of Clinical Urology 2000;15(10):439-440

8.Experimental study on rejection of allogeneic donor bone marrow cells in sensitized recipients.

Lü-hong XU ; Jian-pei FANG ; Wen-jun WENG ; Hong-gui XU ; Qi-xiang YE

Chinese Journal of Hematology 2011;32(11):734-738

9.Summarization of professor Zhang Jia-wei's experiences in treatment of female climacteric syndrome.

Gui-zhen CHEN ; Yun-xiang XU

Chinese Acupuncture & Moxibustion 2007;27(6):447-449

10.Cyclosporin A inhibits the adhesion of neutrophil with ECV-304 induced by hypoxia/reoxygenation via ROS-Cyclophilin A-ERK1/2 pathway.

Si-Gui ZHOU ; Li-Peng XU ; Duan-Fang LIAO ; Xiao-Yong LEI ; Feng-Xiang YAN ; Bing-Yang ZHU

Acta Physiologica Sinica 2004;56(3):313-320

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 103 , 1/11 Show Home Prev Next End page: GO